10-O-VanilloylaucubinCAS# 193969-08-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 193969-08-3 | SDF | Download SDF |
PubChem ID | 10529276 | Appearance | Powder |
Formula | C23H28O12 | M.Wt | 496.5 |
Type of Compound | Iridoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | [(1S,4aR,5S,7aS)-5-hydroxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-7-yl]methyl 4-hydroxy-3-methoxybenzoate | ||
SMILES | COC1=C(C=CC(=C1)C(=O)OCC2=CC(C3C2C(OC=C3)OC4C(C(C(C(O4)CO)O)O)O)O)O | ||
Standard InChIKey | VTYVNBXSLBXSGD-IFWLTBFJSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. 10-O-Vanilloylaucubin shows significant writhing inhibition following oral administration at doses of 25 mg/kg.suggests that it has analgesic effects. |
10-O-Vanilloylaucubin Dilution Calculator
10-O-Vanilloylaucubin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.0141 mL | 10.0705 mL | 20.141 mL | 40.282 mL | 50.3525 mL |
5 mM | 0.4028 mL | 2.0141 mL | 4.0282 mL | 8.0564 mL | 10.0705 mL |
10 mM | 0.2014 mL | 1.007 mL | 2.0141 mL | 4.0282 mL | 5.0352 mL |
50 mM | 0.0403 mL | 0.2014 mL | 0.4028 mL | 0.8056 mL | 1.007 mL |
100 mM | 0.0201 mL | 0.1007 mL | 0.2014 mL | 0.4028 mL | 0.5035 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Fmoc-β-HoPhe-OH
Catalog No.:BCC3241
CAS No.:193954-28-8
- Fmoc- ß-HoIle-OH
Catalog No.:BCC3237
CAS No.:193954-27-7
- Fmoc-ß-HoAla-OH
Catalog No.:BCC3225
CAS No.:193954-26-6
- SC 19220
Catalog No.:BCC6968
CAS No.:19395-87-0
- 3-Phenyl-1,2-dihydroacenaphthylene-1,2-diol
Catalog No.:BCN7178
CAS No.:193892-33-0
- Fmoc-β-Homo-Leu-OH
Catalog No.:BCC2631
CAS No.:193887-44-4
- Tinidazole
Catalog No.:BCC4866
CAS No.:19387-91-8
- Cortistatin 14
Catalog No.:BCC6010
CAS No.:193829-96-8
- SB 242235
Catalog No.:BCC4171
CAS No.:193746-75-7
- Aminoguanidine hydrochloride
Catalog No.:BCC6795
CAS No.:1937-19-5
- 8beta-Methoxyatractylenolide I
Catalog No.:BCN7594
CAS No.:193694-24-5
- Methyl 4-hydroxycinnamate
Catalog No.:BCN4014
CAS No.:19367-38-5
- Cedrelopsin
Catalog No.:BCN7687
CAS No.:19397-28-5
- 6,19-Dihydroxyurs-12-en-3-oxo-28-oic acid
Catalog No.:BCN1513
CAS No.:194027-11-7
- 3-Amino-4-methylbenzamide
Catalog No.:BCC8614
CAS No.:19406-86-1
- Dihydrocapsaicin
Catalog No.:BCN1017
CAS No.:19408-84-5
- Rivulobirin B
Catalog No.:BCN1186
CAS No.:194145-29-4
- Isosaponarin
Catalog No.:BCN2279
CAS No.:19416-87-6
- Isohyenanchin
Catalog No.:BCN1187
CAS No.:19417-00-6
- N-Acetyl-5,6-dehydrololine
Catalog No.:BCN2007
CAS No.:194205-01-1
- Selinidin
Catalog No.:BCN2711
CAS No.:19427-82-8
- Curcumenol
Catalog No.:BCN3522
CAS No.:19431-84-6
- Ac-D-Ala-OH
Catalog No.:BCC3196
CAS No.:19436-52-3
- Benzyl Caffeate
Catalog No.:BCC5100
CAS No.:107843-77-6
Pharmacologically active components of viticis fructus (Vitex rotundifolia). II. The components having analgesic effects.[Pubmed:9579042]
Chem Pharm Bull (Tokyo). 1998 Apr;46(4):655-62.
The extract of Viticis Fructus appeared to have an analgesic effect, and was subjected to activity-guided separation using acetic acid-induced writhing in mice. The active fraction gave new compounds, vitexfolin A (1A), B and C, 10-O-Vanilloylaucubin (3), dihydrodehydrodiconiferylalcohol-beta-D- (2'-O-p-hydroxybenzoyl)glucoside (4), and vanilloyl-beta-D-(2'O-p-hydroxybenzoyl)glucoside, together with agnuside (2) and erythro- and threoguaiacylglycerols. Compounds 1A and 2-4 showed significant writhing inhibition following oral administration at doses of 15, 50, 25, and 50 mg/kg, respectively. The effect on pressure pain threshold was tested using compounds 1A and 2 at a dose of 50 mg/kg, and only the former produced the analgesia. The analgesic effect of some related iridoid glucosides is also discussed.